Search research articles
Contact Us
Filters
Showing results (41-50 of 170) with videos related to
Page
of 17
Sort By:
The Journal of Laboratory and Clinical Medicine
|
April 1, 1983
Urinary 6 beta-hydroxyprednisolone excretion indicates enhanced prednisolone catabolism
F J Frey, B M Frey
European Journal of Clinical Investigation
|
February 1, 1984
Phenytoin modulates the pharmacokinetics of prednisolone and the pharmacodynamics of prednisolone as assessed by the inhibition of the mixed lymphocyte reaction in humans
B M Frey, F J Frey
Schweizerische Medizinische Wochenschrift
|
February 1, 1992
[Glucocorticoids and infection]
F J Frey, R F Speck
Journal of Hypertension
|
March 22, 2000
The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension
P Ferrari, E Lovati, F J Frey
Praxis
|
February 24, 2001
[Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure]
D Fuster, F J Frey, P Ferrari
The Journal of Biological Chemistry
|
May 15, 2001
The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2
A Odermatt, P Arnold, F J Frey
Hormone Research
|
December 12, 2001
Juvenile hypertension, the role of genetically altered steroid metabolism
P Ferrari, M Bianchetti, F J Frey
American Journal of Nephrology
|
January 1, 1991
Autoimmune adrenalitis, asthma and membranoproliferative glomerulonephritis
F J Frey, B Trost, A Zimmermann
Therapeutische Umschau. Revue Therapeutique
|
October 21, 2004
[Rasburicase (Fasturtec)]
B Vogt, M Gugger, F J Frey
Endocrinology
|
July 1, 1994
11 beta-Hydroxysteroid dehydrogenase accounts for low prednisolone/prednisone ratios in the kidney
G Escher, F J Frey, B M Frey
Page
of 17
Search research articles
Search
Showing results (41-50 of 170) with videos related to
Sort By:
Page
of 17
The Journal of Laboratory and Clinical Medicine
|
April 1, 1983
Urinary 6 beta-hydroxyprednisolone excretion indicates enhanced prednisolone catabolism
F J Frey, B M Frey
European Journal of Clinical Investigation
|
February 1, 1984
Phenytoin modulates the pharmacokinetics of prednisolone and the pharmacodynamics of prednisolone as assessed by the inhibition of the mixed lymphocyte reaction in humans
B M Frey, F J Frey
Schweizerische Medizinische Wochenschrift
|
February 1, 1992
[Glucocorticoids and infection]
F J Frey, R F Speck
Journal of Hypertension
|
March 22, 2000
The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension
P Ferrari, E Lovati, F J Frey
Praxis
|
February 24, 2001
[Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure]
D Fuster, F J Frey, P Ferrari
The Journal of Biological Chemistry
|
May 15, 2001
The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2
A Odermatt, P Arnold, F J Frey
Hormone Research
|
December 12, 2001
Juvenile hypertension, the role of genetically altered steroid metabolism
P Ferrari, M Bianchetti, F J Frey
American Journal of Nephrology
|
January 1, 1991
Autoimmune adrenalitis, asthma and membranoproliferative glomerulonephritis
F J Frey, B Trost, A Zimmermann
Therapeutische Umschau. Revue Therapeutique
|
October 21, 2004
[Rasburicase (Fasturtec)]
B Vogt, M Gugger, F J Frey
Endocrinology
|
July 1, 1994
11 beta-Hydroxysteroid dehydrogenase accounts for low prednisolone/prednisone ratios in the kidney
G Escher, F J Frey, B M Frey
Page
of 17